CERS Q4 2020 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$28M+34.8% YoY

Gross Profit

$16M56.8% margin

Operating Income

-$14M-50.9% margin

Net Income

-$14M-51.0% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+19.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$221M

Total Liabilities

$118M

Stockholders' Equity

$104M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$21M	+34.8%
Gross Profit	$16M	$12M	+37.8%
Operating Income	-$14M	-$16M	+12.6%
Net Income	-$14M	-$17M	+15.0%

Revenue Segments

Government Contract

$5M100%

Geographic Segments

Europe Middle East And Africa

$16M58%

North America

$11M41%

Other

$544,0002%